Annual CFF:
-$486.70M-$552.00M(-845.33%)Summary
- As of today, NBIX annual cash from financing is -$486.70 million, with the most recent change of -$552.00 million (-845.33%) on December 31, 2024.
- During the last 3 years, NBIX annual cash from financing has fallen by -$514.10 million (-1876.28%).
- NBIX annual cash from financing is now -194.20% below its all-time high of $516.65 million, reached on December 31, 2017.
Performance
NBIX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFF:
$45.60M+$48.90M(+1481.82%)Summary
- As of today, NBIX quarterly cash from financing is $45.60 million, with the most recent change of +$48.90 million (+1481.82%) on September 30, 2025.
- Over the past year, NBIX quarterly cash from financing has increased by +$19.20 million (+72.73%).
- NBIX quarterly cash from financing is now -91.00% below its all-time high of $506.49 million, reached on June 30, 2017.
Performance
NBIX Quarterly Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
-$365.60M+$19.20M(+4.99%)Summary
- As of today, NBIX TTM cash from financing is -$365.60 million, with the most recent change of +$19.20 million (+4.99%) on September 30, 2025.
- Over the past year, NBIX TTM cash from financing has dropped by -$204.30 million (-126.66%).
- NBIX TTM cash from financing is now -168.82% below its all-time high of $531.25 million, reached on March 31, 2018.
Performance
NBIX TTM Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
NBIX Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -845.3% | +72.7% | -126.7% |
| 3Y3 Years | -1876.3% | +300.0% | -42.2% |
| 5Y5 Years | -1602.2% | +1724.0% | -1365.8% |
NBIX Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -845.3% | at low | -34.8% | +115.6% | -387.9% | +45.8% |
| 5Y | 5-Year | -845.3% | at low | -34.8% | +115.6% | -387.9% | +45.8% |
| All-Time | All-Time | -194.2% | at low | -91.0% | +115.6% | -168.8% | +45.8% |
NBIX Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $45.60M(+1481.8%) | -$365.60M(+5.0%) |
| Jun 2025 | - | -$3.30M(+97.2%) | -$384.80M(+43.0%) |
| Mar 2025 | - | -$117.90M(+59.3%) | -$674.50M(-38.6%) |
| Dec 2024 | -$486.70M(-845.3%) | -$290.00M(-1198.5%) | -$486.70M(-201.7%) |
| Sep 2024 | - | $26.40M(+109.0%) | -$161.30M(+4.5%) |
| Jun 2024 | - | -$293.00M(-519.2%) | -$168.90M(-233.0%) |
| Mar 2024 | - | $69.90M(+97.5%) | $127.00M(+94.5%) |
| Dec 2023 | $65.30M(+127.9%) | $35.40M(+88.3%) | $65.30M(+19.8%) |
| Sep 2023 | - | $18.80M(+548.3%) | $54.50M(+15.7%) |
| Jun 2023 | - | $2.90M(-64.6%) | $47.10M(+120.3%) |
| Mar 2023 | - | $8.20M(-66.7%) | -$232.20M(+0.9%) |
| Dec 2022 | -$234.30M(-955.1%) | $24.60M(+115.8%) | -$234.30M(+8.9%) |
| Sep 2022 | - | $11.40M(+104.1%) | -$257.10M(+1.5%) |
| Jun 2022 | - | -$276.40M(-4631.1%) | -$261.00M(-1518.5%) |
| Mar 2022 | - | $6.10M(+238.9%) | $18.40M(-32.8%) |
| Dec 2021 | $27.40M(+117.4%) | $1.80M(-76.0%) | $27.40M(+117.8%) |
| Sep 2021 | - | $7.50M(+150.0%) | -$153.80M(+3.1%) |
| Jun 2021 | - | $3.00M(-80.1%) | -$158.80M(-8.8%) |
| Mar 2021 | - | $15.10M(+108.4%) | -$146.00M(+7.5%) |
| Dec 2020 | -$157.80M(-587.0%) | -$179.40M(-7276.0%) | -$157.80M(-646.3%) |
| Sep 2020 | - | $2.50M(-84.2%) | $28.88M(-27.0%) |
| Jun 2020 | - | $15.80M(+378.8%) | $39.55M(+41.1%) |
| Mar 2020 | - | $3.30M(-54.7%) | $28.03M(+2.6%) |
| Dec 2019 | $32.40M(+9.8%) | $7.28M(-44.7%) | $27.31M(+25.2%) |
| Sep 2019 | - | $13.16M(+207.3%) | $21.81M(+54.3%) |
| Jun 2019 | - | $4.28M(+66.0%) | $14.14M(-11.5%) |
| Mar 2019 | - | $2.58M(+44.8%) | $15.98M(-45.9%) |
| Dec 2018 | $29.50M(-94.3%) | $1.78M(-67.5%) | $29.53M(-11.4%) |
| Sep 2018 | - | $5.49M(-10.3%) | $33.35M(+8.0%) |
| Jun 2018 | - | $6.12M(-62.1%) | $30.88M(-94.2%) |
| Mar 2018 | - | $16.14M(+188.1%) | $531.25M(+2.8%) |
| Dec 2017 | $516.65M(>+9900.0%) | $5.60M(+85.3%) | $516.65M(+1.1%) |
| Sep 2017 | - | $3.02M(-99.4%) | $511.11M(+0.3%) |
| Jun 2017 | - | $506.49M(>+9900.0%) | $509.42M(>+9900.0%) |
| Mar 2017 | - | $1.53M(+2330.2%) | $3.86M(+61.5%) |
| Dec 2016 | $2.39M(-99.1%) | $63.00K(-95.3%) | $2.39M(-27.5%) |
| Sep 2016 | - | $1.33M(+42.0%) | $3.29M(+21.8%) |
| Jun 2016 | - | $936.00K(+1409.7%) | $2.71M(-23.3%) |
| Mar 2016 | - | $62.00K(-93.6%) | $3.53M(-98.7%) |
| Dec 2015 | $276.99M(+99.7%) | $968.00K(+30.8%) | $276.99M(-0.3%) |
| Sep 2015 | - | $740.00K(-57.9%) | $277.76M(+0.1%) |
| Jun 2015 | - | $1.76M(-99.4%) | $277.50M(+0.5%) |
| Mar 2015 | - | $273.52M(>+9900.0%) | $276.01M(+99.0%) |
| Dec 2014 | $138.73M(+2516.6%) | $1.73M(+257.9%) | $138.73M(+1.2%) |
| Sep 2014 | - | $484.00K(+76.6%) | $137.05M(-1.6%) |
| Jun 2014 | - | $274.00K(-99.8%) | $139.23M(-1.0%) |
| Mar 2014 | - | $136.24M(>+9900.0%) | $140.58M(+2551.4%) |
| Dec 2013 | $5.30M(-93.7%) | $50.00K(-98.1%) | $5.30M(-4.3%) |
| Sep 2013 | - | $2.66M(+63.8%) | $5.54M(+84.9%) |
| Jun 2013 | - | $1.63M(+68.2%) | $3.00M(+111.8%) |
| Mar 2013 | - | $966.00K(+235.4%) | $1.42M(-98.3%) |
| Dec 2012 | $83.70M(>+9900.0%) | $288.00K(+144.1%) | $83.70M(+0.3%) |
| Sep 2012 | - | $118.00K(+174.4%) | $83.44M(+0.1%) |
| Jun 2012 | - | $43.00K(-99.9%) | $83.36M(-0.1%) |
| Mar 2012 | - | $83.25M(>+9900.0%) | $83.48M(>+9900.0%) |
| Dec 2011 | $286.00K(-98.7%) | $22.00K(-51.1%) | $286.00K(-21.2%) |
| Sep 2011 | - | $45.00K(-72.2%) | $363.00K(+6.8%) |
| Jun 2011 | - | $162.00K(+184.2%) | $340.00K(+87.8%) |
| Mar 2011 | - | $57.00K(-42.4%) | $181.00K(-99.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2010 | $21.48M(+117.0%) | $99.00K(+350.0%) | $21.48M(-31.3%) |
| Sep 2010 | - | $22.00K(+633.3%) | $31.28M(+0.1%) |
| Jun 2010 | - | $3000.00(-100.0%) | $31.26M(+0.0%) |
| Mar 2010 | - | $21.36M(+115.7%) | $31.26M(+215.7%) |
| Dec 2009 | $9.90M(+781.8%) | $9.90M(>+9900.0%) | $9.90M(+3700.0%) |
| Sep 2009 | - | $0.00(0.0%) | -$275.00K(+54.2%) |
| Jun 2009 | - | $0.00(0.0%) | -$600.00K(+39.5%) |
| Mar 2009 | - | $0.00(+100.0%) | -$991.00K(+31.7%) |
| Dec 2008 | -$1.45M(-102.5%) | -$275.00K(+15.4%) | -$1.45M(-102.5%) |
| Sep 2008 | - | -$325.00K(+16.9%) | $58.94M(+1.3%) |
| Jun 2008 | - | -$391.00K(+15.2%) | $58.19M(+0.5%) |
| Mar 2008 | - | -$461.00K(-100.8%) | $57.88M(+1.2%) |
| Dec 2007 | $57.18M(+466.9%) | $60.12M(+5702.8%) | $57.18M(+1500.8%) |
| Sep 2007 | - | -$1.07M(-53.5%) | -$4.08M(+7.7%) |
| Jun 2007 | - | -$699.00K(+40.0%) | -$4.42M(-25.1%) |
| Mar 2007 | - | -$1.17M(-1.7%) | -$3.54M(-135.0%) |
| Dec 2006 | $10.09M(-2.4%) | -$1.15M(+19.1%) | $10.09M(-45.5%) |
| Sep 2006 | - | -$1.42M(-844.7%) | $18.50M(-22.7%) |
| Jun 2006 | - | $190.00K(-98.5%) | $23.92M(+0.9%) |
| Mar 2006 | - | $12.46M(+71.3%) | $23.71M(+129.5%) |
| Dec 2005 | $10.33M(-71.8%) | $7.27M(+81.6%) | $10.33M(+344.8%) |
| Sep 2005 | - | $4.00M(>+9900.0%) | $2.32M(-75.5%) |
| Jun 2005 | - | -$19.00K(+97.9%) | $9.49M(-59.3%) |
| Mar 2005 | - | -$922.00K(-24.6%) | $23.30M(-36.5%) |
| Dec 2004 | $36.69M(-82.6%) | -$740.00K(-106.6%) | $36.69M(-29.7%) |
| Sep 2004 | - | $11.17M(-19.0%) | $52.22M(-77.3%) |
| Jun 2004 | - | $13.79M(+10.5%) | $230.16M(+5.0%) |
| Mar 2004 | - | $12.47M(-15.6%) | $219.12M(+3.8%) |
| Dec 2003 | $211.06M(+3532.1%) | $14.79M(-92.2%) | $211.06M(+6.0%) |
| Sep 2003 | - | $189.11M(+6786.8%) | $199.03M(+1605.3%) |
| Jun 2003 | - | $2.75M(-37.8%) | $11.67M(+13.8%) |
| Mar 2003 | - | $4.41M(+60.2%) | $10.25M(+76.4%) |
| Dec 2002 | $5.81M(-96.8%) | $2.75M(+56.9%) | $5.81M(-96.8%) |
| Sep 2002 | - | $1.76M(+32.3%) | $182.06M(+1.1%) |
| Jun 2002 | - | $1.33M(+5014.8%) | $180.17M(-0.4%) |
| Mar 2002 | - | -$27.00K(-100.0%) | $180.88M(-0.2%) |
| Dec 2001 | $181.30M(+92.6%) | $179.01M(>+9900.0%) | $181.30M(+93.6%) |
| Sep 2001 | - | -$140.00K(-106.8%) | $93.65M(-1.7%) |
| Jun 2001 | - | $2.05M(+423.3%) | $95.23M(+2.1%) |
| Mar 2001 | - | $391.00K(-99.6%) | $93.30M(-0.9%) |
| Dec 2000 | $94.13M(+129.6%) | $91.36M(+6275.2%) | $94.13M(+116.9%) |
| Sep 2000 | - | $1.43M(+1114.4%) | $43.39M(+3.0%) |
| Jun 2000 | - | $118.00K(-90.4%) | $42.15M(-0.5%) |
| Mar 2000 | - | $1.22M(-97.0%) | $42.37M(+3.2%) |
| Dec 1999 | $41.00M(+2057.9%) | $40.62M(>+9900.0%) | $41.04M(>+9900.0%) |
| Sep 1999 | - | $188.00K(-44.0%) | $313.00K(-87.9%) |
| Jun 1999 | - | $336.00K(+426.2%) | $2.60M(+33.9%) |
| Mar 1999 | - | -$103.00K(+4.6%) | $1.94M(+0.6%) |
| Dec 1998 | $1.90M(+171.4%) | -$108.00K(-104.4%) | $1.93M(-32.0%) |
| Sep 1998 | - | $2.47M(+868.5%) | $2.84M(+975.9%) |
| Jun 1998 | - | -$321.70K(-180.5%) | $263.60K(-45.7%) |
| Mar 1998 | - | -$114.70K(-114.3%) | $485.30K(-30.7%) |
| Dec 1997 | $700.00K(-98.5%) | $800.00K(+900.0%) | $700.00K(+333.3%) |
| Sep 1997 | - | -$100.00K(0.0%) | -$300.00K(+25.0%) |
| Jun 1997 | - | -$100.00K(-200.0%) | -$400.00K(-101.0%) |
| Mar 1997 | - | $100.00K(+150.0%) | $42.10M(-10.0%) |
| Dec 1996 | $46.80M | -$200.00K(0.0%) | $46.80M(-0.4%) |
| Sep 1996 | - | -$200.00K(-100.5%) | $47.00M(-0.4%) |
| Jun 1996 | - | $42.40M(+783.3%) | $47.20M(+883.3%) |
| Mar 1996 | - | $4.80M | $4.80M |
FAQ
- What is Neurocrine Biosciences, Inc. annual cash from financing?
- What is the all-time high annual cash from financing for Neurocrine Biosciences, Inc.?
- What is Neurocrine Biosciences, Inc. annual cash from financing year-on-year change?
- What is Neurocrine Biosciences, Inc. quarterly cash from financing?
- What is the all-time high quarterly cash from financing for Neurocrine Biosciences, Inc.?
- What is Neurocrine Biosciences, Inc. quarterly cash from financing year-on-year change?
- What is Neurocrine Biosciences, Inc. TTM cash from financing?
- What is the all-time high TTM cash from financing for Neurocrine Biosciences, Inc.?
- What is Neurocrine Biosciences, Inc. TTM cash from financing year-on-year change?
What is Neurocrine Biosciences, Inc. annual cash from financing?
The current annual cash from financing of NBIX is -$486.70M
What is the all-time high annual cash from financing for Neurocrine Biosciences, Inc.?
Neurocrine Biosciences, Inc. all-time high annual cash from financing is $516.65M
What is Neurocrine Biosciences, Inc. annual cash from financing year-on-year change?
Over the past year, NBIX annual cash from financing has changed by -$552.00M (-845.33%)
What is Neurocrine Biosciences, Inc. quarterly cash from financing?
The current quarterly cash from financing of NBIX is $45.60M
What is the all-time high quarterly cash from financing for Neurocrine Biosciences, Inc.?
Neurocrine Biosciences, Inc. all-time high quarterly cash from financing is $506.49M
What is Neurocrine Biosciences, Inc. quarterly cash from financing year-on-year change?
Over the past year, NBIX quarterly cash from financing has changed by +$19.20M (+72.73%)
What is Neurocrine Biosciences, Inc. TTM cash from financing?
The current TTM cash from financing of NBIX is -$365.60M
What is the all-time high TTM cash from financing for Neurocrine Biosciences, Inc.?
Neurocrine Biosciences, Inc. all-time high TTM cash from financing is $531.25M
What is Neurocrine Biosciences, Inc. TTM cash from financing year-on-year change?
Over the past year, NBIX TTM cash from financing has changed by -$204.30M (-126.66%)